Synthesis, DFT, and Molecular Docking Studies of Substituted Benzimidazole Scaffolds as Potential Antimicrobial and Antitubercular Agents
ChemistrySelect · 2026-05 · 11 (18)
DOI: 10.1002/slct.73422 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 11.05.2026. Verfasst von Ramila Gaonkar und 5 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
The rise in antibiotic resistance has become a global health challenge as many of the existing drugs are increasingly ineffective in combating infectious diseases. The benzimidazole hybrids have emerged as new class of antimicrobial agents and as a result there is considerable attention in the design and synthesis of new benzimidazole derivatives. This study describes the synthesis of benzimidazole hybrids and their characterization by FTIR, NMR ( 1 H and 13 C) and mass spectral data. The compounds were screened for antimicrobial potential against the ESKAPE Panel, NTMs, and M. tuberculosis H37Rv27294. Among the tested compounds, 2,4‐dibromo‐6‐(5‐nitro‐1H‐benzo[d]imidazol‐2‐yl)phenol ( 3c ) demonstrated significant potential to inhibit E. faecalis and S. aureus with an MIC values of 1.0 and 0.5 µg/mL, respectively. Compound (3c ) also exhibited immense potential against M. tuberculosis H37Rv27294 with the MIC, 8.0 µg/mL Molecular docking studies on S. aureus tyrosyl‐tRNA synthetase protein, which is essential for bacterial survival, revealed that among all the compounds screened, compound ( 3c ) possesses better affinity with a binding energy of −9.85 kcal/mol. Further, investigation of 3c targeting KasA (β‐ketoacyl‐acyl carrier protein), a crucial enzyme in the mycobacterial FAS‐II pathway, showed a binding energy of −7.1 kcal/mol suggesting 3c could be explore as a promising lead molecule.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Gaonkar, R., Singh, K. S., Tilvi, S., Narayanan, S., Chopra, S., & Thakur, N. (2026). Synthesis, DFT, and Molecular Docking Studies of Substituted Benzimidazole Scaffolds as Potential Antimicrobial and Antitubercular Agents. ChemistrySelect, 11(18). https://doi.org/10.1002/slct.73422
Vancouver
Gaonkar R, Singh KS, Tilvi S, Narayanan S, Chopra S, Thakur N. Synthesis, DFT, and Molecular Docking Studies of Substituted Benzimidazole Scaffolds as Potential Antimicrobial and Antitubercular Agents. ChemistrySelect. 2026;11(18). doi:10.1002/slct.73422
BibTeX
@article{Gaonkar2026,
author = {Gaonkar, Ramila and Singh, Keisham Sarjit and Tilvi, Supriya and Narayanan, Shridhar and Chopra, Siddhart and Thakur, Narsinh},
title = {Synthesis, DFT, and Molecular Docking Studies of Substituted Benzimidazole Scaffolds as Potential Antimicrobial and Antitubercular Agents},
journal = {ChemistrySelect},
year = {2026},
volume = {11},
number = {18},
doi = {10.1002/slct.73422}
}
EUVIMED